In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions. In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co., Ltd. and Taijing Biomedical Research and Development (Beijing) Co., Ltd. and obtained the exclusive patent license of the 1.1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China. Its oral ...


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

秒速赛车计划网页 重庆时时猜龙虎计划 欧乐棋牌 贵州十一选五技巧 辽宁11选5任选一计划 江西快3软件下载 三晋棋牌游戏大厅下载 重庆时时彩计划 稳定版 重庆时时开奖和值走势 七星彩预测最准十专家 街机千炮捕鱼4破解版 智办机器代理赚钱吗 捕鱼达人破解版游戏